VisionGate
Pre-clinicalVisionGate offers the earliest detection of lung cancer when the chance for a cure is the best. Our quick, non-intrusive test is based on 3D cellular imaging and AI. The Cell-CT At the Forefront of Novel Science VisionGate is a biotechnology company
Founded
2007
Focus
DiagnosticsSmall Molecules
About
VisionGate offers the earliest detection of lung cancer when the chance for a cure is the best. Our quick, non-intrusive test is based on 3D cellular imaging and AI. The Cell-CT At the Forefront of Novel Science VisionGate is a biotechnology company
Funding History
3Total raised: $17.5M
Grant$2.5MNational Cancer InstituteApr 15, 2016
Series B$10MUndisclosedSep 15, 2013
Series A$5MUndisclosedMay 15, 2010
Company Info
TypePrivate
Founded2007
LocationPhoenix, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile